{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:30:15Z","timestamp":1708003815015},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.7759\/cureus.21810","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T19:28:55Z","timestamp":1643743735000},"source":"Crossref","is-referenced-by-count":3,"title":["Triple Antithrombotic Therapy (Triple Therapy) After Percutaneous Coronary Intervention in Chronic Anticoagulation: A Literature Review"],"prefix":"10.7759","author":[{"given":"Ali","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.08.021","article-title":"Atrial fibrillation with percutaneous coronary intervention: navigating the minefield of antithrombotic therapies","volume":"289","author":"Bainey KR","year":"2019","unstructured":"Bainey KR, Morais J, Zeymer U, Welsh RC. Atrial fibrillation with percutaneous coronary intervention: navigating the minefield of antithrombotic therapies. Atherosclerosis. 2019, 289:118-25. 10.1016\/j.atherosclerosis.2019.08.021","journal-title":"Atherosclerosis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2021.12.010","article-title":"Angiographic profile and outcomes in persistent non-valvular atrial fibrillation: a study from tertiary care center in North India. (In press)","author":"Sharma YP","year":"2021","unstructured":"Sharma YP, Batta A, Makkar K, et al.. Angiographic profile and outcomes in persistent non-valvular atrial fibrillation: a study from tertiary care center in North India. (In press). Indian Heart J. 2021, 10.1016\/j.ihj.2021.12.010","journal-title":"Indian Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam EA","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al.. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014, 64:e139-228. 10.1016\/j.jacc.2014.09.017","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 61:e78-140. 10.1016\/j.jacc.2012.11.019","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused\u00a0update on duration of dual\u00a0antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines","volume":"68","author":"Levine GN","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, et al.. 2016 ACC\/AHA guideline focused\u00a0update on duration of dual\u00a0antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68:1082-1115. 10.1016\/j.jacc.2016.03.513","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.09.011","article-title":"2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"77","author":"Kumbhani DJ","year":"2021","unstructured":"Kumbhani DJ, Cannon CP, Beavers CJ, et al.. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021, 77:629-58. 10.1016\/j.jacc.2020.09.011","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.12.026","article-title":"Triple vs dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease","volume":"129","author":"Lopes RD","year":"2016","unstructured":"Lopes RD, Rao M, Simon DN, et al.. Triple vs dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. Am J Med. 2016, 129:592-99.e1. 10.1016\/j.amjmed.2015.12.026","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz732","article-title":"Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials","volume":"40","author":"Gargiulo G","year":"2019","unstructured":"Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T, Vranckx P, Valgimigli M. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J. 2019, 40:3757-67. 10.1093\/eurheartj\/ehz732","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open label, randomized, controlled trial","volume":"381","author":"Dewilde WJ","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, et al.. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open label, randomized, controlled trial. Lancet. 2013, 381:1107-15. 10.1016\/s0140-6736(12)62177-1","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial","volume":"65","author":"Fiedler KA","year":"2015","unstructured":"Fiedler KA, Maeng M, Mehilli J, et al.. Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol. 2015, 65:1619-29. 10.1016\/j.jacc.2015.02.050","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson CM","year":"2016","unstructured":"Gibson CM, Mehran R, Bode C, et al.. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016, 375:2423-34. 10.1056\/NEJMoa1611594","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon CP","year":"2017","unstructured":"Cannon CP, Bhatt DL, Oldgren J, et al.. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017, 377:1513-24. 10.1056\/NEJMoa1708454","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes RD","year":"2019","unstructured":"Lopes RD, Heizer G, Aronson R, et al.. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019, 380:1509-24. 10.1056\/NEJMoa1817083","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx P","year":"2019","unstructured":"Vranckx P, Valgimigli M, Eckardt L, et al.. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet. 2019, 394:1335-43. 10.1016\/S0140-6736(19)31872-0","journal-title":"Lancet"},{"key":"ref15","article-title":"Use of CHA2DS2-VASc score in patients without atrial fibrillation: review of literature","volume":"1","author":"Tahir H","year":"2021","unstructured":"Tahir H, Sarwar U, Hussain A, et al.. Use of CHA2DS2-VASc score in patients without atrial fibrillation: review of literature. J Card Cardi Sur. 2021, 1:05.","journal-title":"J Card Cardi Sur"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen JB","year":"2011","unstructured":"Olesen JB, Lip GY, Hansen ML, et al.. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011, 342:d124. 10.1136\/bmj.d124","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters R","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010, 138:1093-100. 10.1378\/chest.10-0134","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl SR","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002, 288:2411-20. 10.1001\/jama.288.19.2411","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.036","article-title":"Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation","volume":"61","author":"Sarafoff N","year":"2013","unstructured":"Sarafoff N, Martischnig A, Wealer J, Mayer K, Mehilli J, Sibbing D, Kastrati A. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. J Am Coll Cardiol. 2013, 61:2060-6. 10.1016\/j.jacc.2013.02.036","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective-2018 update","volume":"138","author":"Angiolillo DJ","year":"2018","unstructured":"Angiolillo DJ, Goodman SG, Bhatt DL, et al.. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective-2018 update. Circulation. 2018, 138:527-36. 10.1161\/CIRCULATIONAHA.118.034722","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 383:955-62. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7326\/M19-3763","article-title":"Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"172","author":"Khan SU","year":"2020","unstructured":"Khan SU, Osman M, Khan MU, et al.. Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis. Ann Intern Med. 2020, 172:474-83. 10.7326\/M19-3763","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda S","year":"2019","unstructured":"Yasuda S, Kaikita K, Akao M, et al.. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019, 381:1103-13. 10.1056\/NEJMoa1904143","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036768","article-title":"Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation","volume":"139","author":"Matsumura-Nakano Y","year":"2019","unstructured":"Matsumura-Nakano Y, Shizuta S, Komasa A, et al.. Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation. Circulation. 2019, 139:604-16. 10.1161\/CIRCULATIONAHA.118.036768","journal-title":"Circulation"},{"key":"ref25","article-title":"Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants","volume":"13","author":"Garkina SV","year":"2016","unstructured":"Garkina SV, Vavilova TV, Lebedev DS, Mikhaylov EN. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. J Geriatr Cardiol. 2016, 13:807-10.","journal-title":"J Geriatr Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034778","article-title":"Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"10","author":"Salmasi S","year":"2020","unstructured":"Salmasi S, Loewen PS, Tandun R, Andrade JG, De Vera MA. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open. 2020, 10:e034778. 10.1136\/bmjopen-2019-034778","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84859-triple-antithrombotic-therapy-triple-therapy-after-percutaneous-coronary-intervention-in-chronic-anticoagulation-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:18Z","timestamp":1707507378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84859-triple-antithrombotic-therapy-triple-therapy-after-percutaneous-coronary-intervention-in-chronic-anticoagulation-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.21810","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}